Spouse's Role Seen in Hughes Shakeup

WASHINGTON—The sudden and unexplained departure of Donald Fredrickson as president of the Howard Hughes Medical Institute is due chiefly to conflicts arising from his wife's participation in HHMI activities that exceeded the normal bounds of a spouse's interests, say several longtime friends and colleagues. According to these associates, Fredrickson's wife has played an active role in certain affairs of the $5 billion organization since Fredrickson became affiliated with the institute in 1

Written byRon Cowen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

According to these associates, Fredrickson's wife has played an active role in certain affairs of the $5 billion organization since Fredrickson became affiliated with the institute in 1983. She has attended numerous meetings of the trustees, was instrumental in the departure of an HHMI employee, pushed through a lavish plan to furnish her husband's offices at the institute's new home in Bethesda, and attended meetings on the Research Scholars Program, an HHMI-supported program that offers medical students a year of research experience in an NIH laboratory.

George Thorn, chairman of the institute and acting chief executive officer, refused to comment about whether Fredrickson's wife, Henrietta, played a role in his decision April 20 to take an indefinite leave of absence. According to a statement released by the institute, "the trustees are conducting a review of certain administrative activities in Bethesda during the past two years." Thorn said that a report ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies